Table 4.
Treatment | Doses (mg/kg) |
GSH (mg/gprotein) |
MDA (nmol/mgprotein) |
SOD (U/mg protein) |
---|---|---|---|---|
Normal control |
—— |
3.00 ± 0.14 |
1.03 ± 0.22 |
262.95 ± 30.43 |
CCl4 |
—— |
1.85 ± 0.28## |
3.00 ± 0.45## |
151.95 ± 20.25## |
Matrine + CCl4 |
50 |
2.36 ± 0.53** |
2.52 ± 0.87 |
151.74 ± 11.44 |
Salvianolic acid B + CCl4 |
150 |
2.16 ± 0.65 |
2.12 ± 0.43** |
159.85 ± 22.28 |
|
25 |
2.28 ± 0.59* |
2.58 ± 0.62 |
169.94 ± 25.16 |
Matrine salvianolic acid B Salt + CCl4 |
50 |
2.48 ± 0.33** |
2.11 ± 0.31** |
184.65 ± 24.90**ab |
|
100 |
2.63 ± 0.29**b |
1.79 ± 0.43**a |
191.71 ± 48.32**ac |
Fu fang bie jia ruan gan pian + CCl4 | 780 | 2.52 ± 0.32** | 1.76 ± 0.76** | 171.39 ± 28.90 |
Data is expressed as the mean±SD (n = 12).
##p < 0.01 vs. the normal control group; *p < 0.05, **p < 0.01 vs. the CCl4-treated group;
ap < 0.01 vs. the Matrine group; bp < 0.05, cp < 0.01 vs. the Salvianolic acid B group.